King Pharmaceuticals KG General Liability — Year 9
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's general liability — year 9.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's general liability — year 9?
- King Pharmaceuticals (KG) reported general liability — year 9 of 3.8% in Q4 2025.
- What does general liability — year 9 mean?
- Represents the total revenue or financial activity generated by the General Liability insurance segment during the ninth year of the reporting period. This metric is essential for assessing the maturity and revenue consistency of the company's primary liability insurance offerings.